Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders.
about
MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study).Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.Blood assessment of the expression levels of matrix metalloproteinase 9 (MMP9) and its natural inhibitor, TIMP1 genes in Iranian schizophrenic patients.Possible association between serum matrix metalloproteinase-9 (MMP-9) levels and relapse in depressed patients following electroconvulsive therapy (ECT).
P2860
Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Altered Serum Levels of Matrix ...... ve Therapy for Mood Disorders.
@en
Altered Serum Levels of Matrix ...... ve Therapy for Mood Disorders.
@nl
type
label
Altered Serum Levels of Matrix ...... ve Therapy for Mood Disorders.
@en
Altered Serum Levels of Matrix ...... ve Therapy for Mood Disorders.
@nl
prefLabel
Altered Serum Levels of Matrix ...... ve Therapy for Mood Disorders.
@en
Altered Serum Levels of Matrix ...... ve Therapy for Mood Disorders.
@nl
P2093
P2860
P356
P1476
Altered Serum Levels of Matrix ...... ve Therapy for Mood Disorders.
@en
P2093
Chiyo Shibasaki
Hiromi Abe
Kei Itagaki
Mami Okada-Tsuchioka
Minoru Takebayashi
Naoto Kajitani
Shigeto Yamawaki
P2860
P356
10.1093/IJNP/PYW019
P577
2016-02-23T00:00:00Z